How much does Vizimpro (Dacomitinib Tablets) Cost& price without insurance in China?
Vizimpro® is the commercial brand name of Dacomitinib Tablets, an orally active irreversible pan-EGFR tyrosine kinase inhibitor developed by Pfizer. It irreversibly inhibits EGFR, HER2 and HER4 kinase activity to block downstream oncogenic signaling and suppress non-small cell lung cancer proliferation.
Main Indications
First-line treatment for adult patients with locally advanced or metastatic non-small cell lung cancer harboring activating EGFR gene mutations.
Common Side Effects
Common mild adverse reactions: Diarrhea, acneiform rash, stomatitis, dry skin and nail disorders.
Laboratory abnormalities: Transient mild elevation of hepatic transaminases.
Severe but manageable risks: Severe refractory diarrhea, interstitial lung disease and severe cutaneous adverse reactions.
Approval Status in China
Vizimpro® (Dacomitinib Tablets, 15mg) was officially approved for marketing in China in 2019. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Vizimpro (Dacomitinib Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
